QSAM Biosciences 10K 2019 Annual report | QSAM Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: ablation, ABS, accomplish, afflicting, Agrarian, ahead, alongside, aware, Baum, BBS, bio, bioscience, bone, boost, breakthrough, cancer, carryforward, cashflow, CECO, CEP, children, clinical, compassionate, compromised, cycle, devastating, distributorship, DOTMP, drug, Eco, England, FDA, flexibility, foreclose, formation, herewith, IGL, impediment, indefinitely, infusion, inventor, Language, licensor, Linkbase, load, Macuclear, marrow, metastasized, MSTC, nutrient, omitted, osteosarcoma, overcome, overseen, page, pandemic, patient, pediatric, percentage, Pharma, pharmaceutical, PIK, proximity, Quadramet, radiopharmaceutical, Richard, root, Schema, seller, shortfall, shut, single, solvency, Stewart, strength, strike, stronger, structured, Taxonomy, translate, treat, trial, unaudited, unbilled, unvested, USDA, vascular, visible, vulnerable, Wild, XBRL

Removed: accretion, adjusted, adjustment, advertising, agreed, allocated, amortized, arrangement, assessing, assured, Australia, branded, collectability, command, consolidating, continually, deliverable, delivered, delivery, EisnerAmper, embedded, executed, expensed, feature, FINANCAL, forgave, Hedging, identification, initially, intent, lacking, letter, list, LLP, maximizing, milestone, network, NOBO, overlapping, prepayment, project, reclassified, recover, redeemed, reliant, safety, training, unamortized, unconverted, undelivered

QSAM Biosciences (QSAM) 10-K2019 FY Annual report

Content analysis